Corticosteroid therapy augments gastroduodenal permeability to sucrose
暂无分享,去创建一个
S. Saip | A. Siva | Türcan Gürcan | C. Kalayci | N. Ulusoy | Ş. Kızıltaş | N. Imeryüz | A. Dumankar | C. Kalaycı
[1] M. Kasuga,et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. , 1997, Gastroenterology.
[2] D. Graham,et al. Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose. , 1996, Gut.
[3] H J Hodgson,et al. Corticosteroids reduce regenerative repair of epithelium in experimental gastric ulcers. , 1995, Gut.
[4] C. V. Van Itallie,et al. Tight junctions and the molecular basis for regulation of paracellular permeability. , 1995, The American journal of physiology.
[5] A. Macpherson,et al. Intestinal permeability: an overview. , 1995, Gastroenterology.
[6] J. Wallace,et al. A simple, non-invasive marker of gastric damage: sucrose permeability , 1994, The Lancet.
[7] S. Reingold,et al. Megadose corticosteroids in multiple sclerosis , 1994, Neurology.
[8] J. Alverdy,et al. The effect of dexamethasone administration on rat intestinal permeability: the role of bacterial adherence. , 1994, Gastroenterology.
[9] J. Wallace,et al. Sucrose: a novel permeability marker for gastroduodenal disease. , 1993, Gastroenterology.
[10] D. Newman,et al. Brainstem reticular nuclei that project to the thalamus in rats: a retrograde tracer study , 1992 .
[11] E. D. Jacobson. Circulatory mechanisms of gastric mucosal damage and protection. , 1992, Gastroenterology.
[12] H R Herschman,et al. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. , 1992, The Journal of biological chemistry.
[13] P. Braquet,et al. Dexamethasone‐induced gastric mucosal damage in the rat: possible role of platelet‐activating factor , 1992, British journal of pharmacology.
[14] J. Alverdy,et al. The Effect of Glucocorticoid Administration on Bacterial Translocation: Evidence for an Acquired Mucosal Immunodeficient State , 1991, Annals of surgery.
[15] P. Scheltens,et al. Quantitative MRI changes in gadolinium‐DTPA enhancement after high‐dose intravenous methylprednisolone in multiple sclerosis , 1991, Neurology.
[16] W A Ray,et al. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. , 1991, Annals of internal medicine.
[17] E. Swabb,et al. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. , 1988, Gastroenterology.
[18] J. Wallace. Glucocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but not prostaglandin biosynthesis. , 1987, Prostaglandins.
[19] D. K. Brown,et al. Peptic ulcer perforation associated with steroid use. , 1987, Archives of surgery.
[20] A. Levi,et al. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. , 1986, Gut.
[21] T. Omae,et al. Adrenocorticosteroid therapy and gastroduodenal lesions. , 1985, Gastrointestinal endoscopy.
[22] H. Spiro. Is the steroid ulcer a myth? , 1983, The New England journal of medicine.
[23] T C Chalmers,et al. Association of adrenocorticosteroid therapy and peptic-ulcer disease. , 1983, The New England journal of medicine.
[24] H O Conn,et al. Nonassociation of adrenocorticosteroid therapy and peptic ulcer. , 1976, The New England journal of medicine.
[25] B. Brenner,et al. Glomerular ultrafiltration. , 1974, Federation proceedings.
[26] R. Menguy,et al. Effect of cortisone on mucoprotein secretion by gastric antrum of dogs: pathogenesis of steroid ulcer. , 1963, Surgery.
[27] W. Kanenson,et al. The incidence of peptic ulcer among patients on long term prednisone therapy. , 1958, Gastroenterology.